Tranexamic acid as initial treatment for unresectable metastatic colorectal cancer

Tranexamic acid and chemotherapy as initial treatment for unresectable metastatic colorectal cancer

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs031180417

Enrollment

100

Registered

2019-03-22

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Colorectal Cancer

Interventions

Off-label use

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Metastatic Colorectal Cancer

Exclusion criteria

Exclusion criteria: Treatment with anticoagulants (Aspirin,Warfarin)

Design outcomes

Primary

Measure	Time frame
Progression-free Survival:PFS	—

Secondary

Measure	Time frame
Overall Survival:OS,Time to Treatment Failure:TTF	—

Contacts

Public ContactShinya Munakata

Juntendo university Hospital

smunaka@juntendo.ac.jp+81-3-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026